首页
热心肠日报
文献库
产业库
榜单
关于日报
《肠·道》演讲
往期精彩
《肠·道》2024
《肠·道》2023
《肠·道》2022
《肠·道》2021
《肠·道》2020
《肠·道》2019
《肠·道》2018
《肠·道》2017
关于《肠·道》
肠道大会
热心肠大会
热心肠智库
智库专家
专家动态
智库新闻
关于智库
奖学金
年度人物奖
更多
HOPE
会议信息
科学与艺术
学术专刊
R·AI
周刊
热心肠先生
研究院动态
关于我们
搜索
登录
关闭
手机邮箱登录
扫码登录
微信扫描二维码快捷登录
验证成功,将在
3
秒钟后跳转
已超时,请
重试
关闭
二维码登录
手机登录
邮箱登录
+86
+1
+852
+886
+81
+65
+61
+44
获取验证码
登录 / 注册
关闭
二维码登录
手机登录
邮箱登录
获取验证码
登录 / 注册
热心肠智库
专家文章 | 马雄
2024
CA
Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitis
J Autoimmun, 10.1016/j.jaut.2023.103163
CA
Itaconate inhibits CD103 + T RM cells and alleviates hepatobiliary injury in mouse models of primary sclerosing cholangitis
Hepatology, 10.1097/HEP.0000000000000549
2023
CA
MGAT5/TMEM163 variant is associated with prognosis in ursodeoxycholic acid-treated patients with primary biliary cholangitis
J Gastroenterol, 10.1007/s00535-023-02045-z
CA
Fine mapping identifies independent HLA associations in autoimmune hepatitis type 1
JHEP REP, 10.1016/j.jhepr.2023.100926
CA
A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis
J HEPATOL, 10.1016/j.jhep.2023.08.016
CA
The S100 calcium-binding protein A6 plays a crucial role in hepatic steatosis by mediating lipophagy
Hepatol Commun, 10.1097/HC9.0000000000000232
CA
Autoimmune Hepatitis: Pathophysiology
CLIN LIVER DIS, 10.1016/j.cld.2023.06.003
CA
ARID3a from the ARID family: structure, role in autoimmune diseases and drug discovery
APS, 10.1038/s41401-023-01134-2
CA
A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expression
Nat Commun, 10.1038/s41467-023-37213-5
CA
P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases
Hepatology, 10.1097/HEP.0000000000000317
CA
Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells
J Autoimmun, 10.1016/j.jaut.2023.102993
2022
CA
The immunological characteristics of TSPAN1 expressing B cells in autoimmune hepatitis
Front Immunol, 10.3389/fimmu.2022.1076594
CA
Tissue-resident memory T cells in chronic liver diseases: Phenotype, development and function
Front Immunol, 10.3389/fimmu.2022.967055
CA
Intrahepatic activated leukocyte cell adhesion molecule induces CD6highCD4+ T cell infiltration in autoimmune hepatitis
Front Immunol, 10.3389/fimmu.2022.967944
CA
Intrahepatic activated leukocyte cell adhesion molecule induces CD6highCD4+ T cell infiltration in autoimmune hepatitis
Front Immunol, 10.3389/fimmu.2022.967944
CA
Intrahepatic activated leukocyte cell adhesion molecule induces CD6highCD4+ T cell infiltration in autoimmune hepatitis
Front Immunol, 10.3389/fimmu.2022.967944
CA
Intrahepatic activated leukocyte cell adhesion molecule induces CD6highCD4+ T cell infiltration in autoimmune hepatitis
Front Immunol, 10.3389/fimmu.2022.967944
CA
Intrahepatic activated leukocyte cell adhesion molecule induces CD6highCD4+ T cell infiltration in autoimmune hepatitis
Front Immunol, 10.3389/fimmu.2022.967944
CA
Intestinal homeostasis in autoimmune liver diseases
Chin Med J, 10.1097/CM9.0000000000002291
CA
NUDT1 promotes the accumulation and longevity of CD103+ TRM cells in primary biliary cholangitis
J HEPATOL, 10.1016/j.jhep.2022.06.014